WAYFIND-R is a global registry that enrols patients with solid tumours profiled with a next-generation sequencing (NGS) test and that collects data on patient and tumour characteristics, and their outcomes. It aims to enable collaborations and provide meaningful insights and high-quality evidence to enhance our understanding of precision oncology and ultimately transform the lives of people with cancer.
The WAYFIND-R Data Availability Dashboard shows aggregated data from all participating sites and will support to inform research with insights from aggregated data and address questions like:
Additionally, access to anonymised individual-level data from the WAYFIND-R global database can be requested to perform registry-based studies.